Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
Elevating Care for Patients With Severe Renal Disease in AAV
Andreas Kronbichler, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
Managing Patients With AAV in the Rheumatology Clinic
Implementing the SOC Induction Therapies in AAV
Setting the Stage of Real-World Data vs RCT
Renato D. Lopes, MD, MHS, PhD
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Valeria Caso, MD, PhD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
John Russell, MD
Noel Dasgupta, MD, FACC
Sami Khella, MD
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Scott Solomon, MD
HF Management for Patients with Comorbid Conditions
Neil Skolnik, MD
Barry Greenberg, MD
Karina Brown, BSN, RN
Jessica Lin, MPAP
Melissa Mclenon, DNP, ACNP-BC
Level Up Your Skills: Tailoring Management of HF
Trina Huynh, PharmD
Partnering with Patients: Building Effective Communication and Support in HF Care
Brian P. McDonough, MD, FAAFP
A Practical Guide to Prescribing in HF
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
Optimizing Heart Failure Management
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.